Vector Control
Our Recommendations
- Global Malaria Programme operational strategy 2024–2030 (2024)
- Lignes directrices de l'OMS sur le paludisme (2022)
- Guidelines for malaria vector control (2019)
- Zika Virus Infection: Step by Step Guide on Risk Communication and Community Engagement (2016)
- Guidelines for laboratory and field-testing of long-lasting insecticidal nets (2013)
New Publications
- Orientações sobre o uso de vacinas contra a varíola símia. Edição corrigida (2024)
- Orientaciones sobre el uso de las vacunas contra la viruela símica. Edición corregida (2024)
- Guidance on the use of mpox vaccines. Revised edition (2024)
- HEARTS in the Americas. Compendium of essential clinical tools 2023 (2024)
- HEARTS en las Américas: Compendio de herramientas clínicas esenciales 2023 (2024)
Filter
267
Featured
Recommendations
21
New Publications
59
Language
Document type
No document type
121
Studies & Reports
40
Guidelines
38
Strategic & Response Plan
22
Manuals
19
Fact sheets
10
Training Material
9
Online Courses
3
Videos
2
Brochures
1
Situation Updates
1
Infographics
1
Countries / Regions
Global
42
Latin America and the Carribbean
29
Africa
20
India
6
Malawi
4
South–East Asia Region
4
Western and Central Europe
4
Sudan
4
Ethiopia
4
Middle East and North Africa
3
North America
3
Brazil
3
South Sudan
3
Somalia
3
Kenya
2
Mexico
2
Ghana
2
Sierra Leone
2
China
2
Syria
2
Senegal
2
Zimbabwe
2
Guinea
2
Asia
2
Jordan
2
Saudi Arabia
2
Congo, Democratic Republic of
2
West and Central Africa
2
Western Pacific Region
2
Côte d’Ivoire / Ivory Coast
2
Bangladesh
2
Greece
2
Angola
2
Liberia
2
Nepal
1
Thailand
1
Turkey
1
Cameroon
1
Iran
1
Nigeria
1
Albania
1
Burkina Faso
1
Morocco
1
Mozambique
1
USA
1
Germany
1
Eastern Europe and Central Asia
1
Tunisia
1
Spain
1
East and Southern Africa
1
Bolivia
1
Lebanon
1
South Africa
1
Uganda
1
Eastern Europe
1
Russia
1
Egypt
1
Yemen
1
Georgia
1
Mali
1
Chad
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Disease Prevention & Control
180
Vector Control
39
Communicable Diseases
35
Non-communicable Diseases
30
Chagas
21
Leishmaniasis
16
Malaria
14
Policies
11
Studies & Reports
11
Guidelines
10
Capacity Building
8
NTDs & Others
8
Health System Strengthening
7
Sanitation
6
Vaccine-preventable Diseases
6
Communicable Diseases
6
Water
6
General Guidelines
5
Pharmacy & Technologies
5
Infection Control & Prevention (IPC)
4
Countries
4
General Guidelines
4
Public Health
3
Disaster Preparedness
3
Public Health
3
NCD
3
Diarrhoeal Disease/Cholera
3
Immunization
3
Women & Child Health
3
Parasitology
3
Rabies
2
Helminthiasis
2
Trachoma
2
COVID-19
2
Hemorrhagic Fever
2
Yellow Fever
2
WASH
2
Key Resources
2
Dental & Eye Care
1
Clinical Training
1
Hepatitis
1
Diabetes
1
Hand Hygiene
1
Online Courses & Platforms
1
Monitoring & Evaluation
1
Community Health
1
Videos
1
Pediatrics
1
Humanitarian Aid
1
Cardiovascular Diseases
1
Dracunculiasis
1
Clinical Guidelines
1
Drugs & Medical Equipment
1
Women & Child Health
1
Humanitarian Crisis
1
Respiratory Infections
1
Surgery & Anaesthesia
1
Needs Assessment
1
Protection & Security
1
Nutrition
1
Primary Health Care
1
Dengue
1
Laboratory Technologies
1
Human African Trypanosomiasis
1
TB
1
Toolboxes
Public Health
20
Chagas
20
Overview, Studies & Reports
20
Leishmaniasis
15
Vector control
12
Studies & Reports
9
Yellow Fever Prevention & Control
6
Risk Communication & Community Engagement
6
Outbreak Prevention & Control
5
IPC
5
Key Resources
5
Training
5
Zika Prevention & Control
5
Meningitis Prevention & Control
4
Surveillance
4
Cholera Prevention & Control
4
Infectious Diseases
4
NTDs
4
NTDs General
4
Dengue Prevention & Control
4
Communication & Training
3
Vector Control
3
Prevention & Control
3
Pharmacy
3
One Health
3
Statistics & Facts
3
Food & Nutrition
3
Preparedness & Prevention
3
Treatment Guidelines
2
Ebola Prevention & Control
2
Communication & Training
2
Infection Control
2
Infection Control General
2
Workplace
2
Public Health
2
Strategies & Roadmaps
2
Clinical Guidelines
2
Drug resistant TB
2
Disease Prevention & Control
2
Chikungunya Prevention & Control
2
Infection Control
2
Clinical Guidelines
1
Clinical Aspects
1
Social Mobilisation
1
Policies
1
Sexually Transmitted Infections
1
Communication & Training
1
HIV
1
Training Material
1
Communication
1
Workplace
1
Sustainable Development Goals
1
Key Resources
1
General
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
COVID-19
1
Public Health
1
Risk Communication & Community Engagement
1
Surveillance & Contact tracing
1
Covid-19 & the One Health Approach
1
For Health Worker
1
Country specific documents
1
Prison & Detention
1
Human Rights
1
Infection Control & Prevention (IPC)
1
Mythbusters/Misinformation
1
Tips & Best Practice Examples
1
Planetary Health
1
Essential Medicines
1
General documents One Health
1
Agriculture incl. animal husbandry
1
Zoonoses
1
Non-communicable Diseases NCD
1
Health Care In Conflict Settings
1
Dengue & Chikungunya
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Policies & Strategies
1
Other NTDs
1
Policies and guidelines
1
Neurological Disorders
1
Zika
1
Assessment & Response
1
Assessment & Response
1
Malawi
1
One Health
1
Global Health Education
1
Nutrition
1
Disaster Preparedness & Prevention
1
TB/HIV Coinfection
1
Tobacco
1
Other Resources
1
Cholera
1
WASH
1
Context & Facts
1
Action Plans, Policies & Response
1
Meningitis & Encephalitis
1
Capacity Building
1
Risk Communication & Community Engagement
1
Plague Prevention & Control
1
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Chagas disease is caused by Trypanosoma cruzi, a protozoal organism primarily transmitted by triatomine insect vectors, also known as “kissing bugs.” It is a zoonotic disease originally described by Brazilian physician Dr. Carlos Chagas in 1909 and is widespread in Latin America. Although triato...
Goal and objectives of the guideline
The goal of this guideline is to provide evidence-based recommendations to countries in their efforts to accomplish schistosomiasis morbidity control and elimination as a public health problem, and to move towards interruption of transmission.
The recommendatio...
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding resea...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Chagas disease (CD) is a neglected tropical disease, endemic in Latin America, but due to migration and environmental changes it has become a global public health issue.
Chagas disease constitutes a public health problem, and Spain is the non-endemic country with the highest burden of disease outside the Americas. It represents a model for non-endemic countries regarding health policies to control the disease. This study is aimed to generate estimates of the T.cruzi...
Little progress has been made since the 1960s and 1970s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and operational challenges in the clinica...
Chagas disease (CD) is caused by Trypanosoma cruzi. When acquired, the
disease develops in stages. For diagnosis, laboratory confirmation is required, and an extensive assessment of the patient’s health should be performed. Treatment consists of the administration of trypanocidal drugs, which may...
Objective
To estimate the prevalence of Chagas disease in pregnant women and the vertical transmission of the disease.
Methods
Observational studies were identified from eight electronic databases, and details on study design, population and prevalence of Chagas disease were extracted. The data...
This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector. The flagellate mainly colonizes the intestinal tract of the insect. The effect of triatomines on trypanosomes is indicated by susceptibility and refractoriness phenom...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
American trypanosomiasis, commonly called
Chagas disease (CD), was prevalent once in rural areas
of Latin America where poverty is widespread and was
considered a silent and poorly visible disease. It
has become a global neglected tropical disease and a
significant public health th...
Coherent Market Insights has announced the addition of Chagas Disease Treatment Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Chagas Disease Treatment Market has been thoroughly researched and an...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Leishmaniasis is an important worldwide disease with a
zoonotic potential that presenting visceral and cutaneous
clinical forms. The domestic dog is seen as the main reservoir of Leishmania spp. and for this reason, it is the target of
the control program in some countries. The health professiona...
Leishmaniasis is an infection caused by the Leishmania parasites. The infection is transmitted by the bite of infected phlebotomine sandfly. There are over 20 types of Leishmania parasites which cause infection in people and 30 different types of sand flies to spread infection. Leishmaniasis is wide...
